All news

Neuronetics stock tumbles 10% on stock offering launch

Alpha Vantage · Investing.com · · AI-summarised by FinFlash

Neuronetics Inc (NASDAQ:STIM) shares dropped 10% in after-hours trading after the company announced a public offering of common stock and an amendment to its credit agreement. The mental health technology company plans to sell all shares in the offering and has granted underwriters a 30-day option for an additional 15%.

Read original source

STIM company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.